Browsing by Subject "Randomization"
Now showing items 1-7 of 7
-
Article
Asynchronous gossip
(2013)We study the complexity of gossip in an asynchronous, message-passing fault-prone distributed system. We show that an adaptive adversary can significantly hamper the spreading of a rumor, while an oblivious adversary cannot. ...
-
Article
Chlamydia pneumoniae infection and the risk of multiple sclerosis: A meta-analysis
(2006)We conducted a meta-analysis of studies comparing the presence of Chlamydia pneumoniae (Cpn) between multiple sclerosis (MS) patients and other neurological diseases patients or healthy controls. We identified 26 studies ...
-
Conference Object
The impact of randomization in smoothing networks
(2008)We revisit smoothing networks[3], which are made up of balancers and wires. Tokens arrive arbitrarily on w input wires and propagate asynchronously through the network
-
Article
The impact of randomization in smoothing networks
(2010)We revisit randomized smoothing networks (Herlihy and Tirthapura in J Parallel Distrib Comput 66(5):626-632, 2006), which are made up of balancers and wires. We assume that balancers are oriented independently and uniformly ...
-
Article
A method for meta-analysis of case-control genetic association studies using logistic regression
(2007)We propose here a simple and robust approach for meta-analysis of molecular association studies. Making use of the binary structure of the data, and by treating the genotypes as independent variables in a logistic regression, ...
-
Conference Object
On the complexity of asynchronous gossip
(2008)In this paper, we study the complexity of gossip in an asynchronous, message-passing fault-prone distributed system. In short, we show that an adaptive adversary can significantly hamper the spreading of a rumor, while an ...
-
Article
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer
(2005)The irinotecan-cisplatin combination has emerged as a new standard for the treatment of advanced-stage small-cell lung cancer (AS-SCLC). To move forward we developed a 3-day regimen of cisplatin, etoposide and irinotecan. ...